LLY
Eli Lilly and Company
LLY has the edge over RVTY overall, supported by stronger valuation and stronger modeled upside.
RVTY
Revvity, Inc.
RVTY's outlook is improving despite an expensive valuation.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
RVTY Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Stable |
RVTY's profitability and cash flow are currently healthy, and its revenue and balance sheet are stable.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY has the edge over RVTY in the historical PE scenario, which offers more potential upside but is not a forecast.
RVTY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 18x | $40.50 | -74% |
| Forward | 27x | $157 | — |
| Fair | 37x | $84.05 | -46% |
| Expensive | 54x | $121 | -23% |
| Current | 70x | $157 | — |
Historical ranges are pointers, not guarantees.
RVTY's PE is in its expensive range at 70x. If earnings grow as analysts expect, today's price would be 27x next year's earnings, in its fair range.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
LLY has the edge over RVTY on the outlook, with more favorable revenue expectations.
RVTY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect RVTY's earnings to grow and its profitability to improve, with its revenue holding steady.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over RVTY on earnings, with more consistent year-over-year improvement.
RVTY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.81 | +158% |
| Q3 2026 | $2.25 | +14% |
| Q2 2026 | $2.09 | -11% |
| Q1 2026 | $2.08 | -11% |
| Q4 2025 | $2.07 | -5.9% |
| Q3 2025 | $1.98 | -6.6% |
| Q2 2025 | $2.35 | +64% |
| Q1 2025 | $2.34 | +86% |
| Q4 2024 | $2.20 | -60% |
RVTY's earnings per share have fallen from their peak: $2.25 over the past year, against $10.51 in mid-2021.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over RVTY on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over RVTY on profitability, with a higher operating margin.
RVTY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $728.9M | +4.3% |
| Q2 2026 | $729.7M | +1.3% |
| Q1 2026 | $711.1M | +7% |
| Q4 2025 | $772.1M | +5.9% |
| Q3 2025 | $698.9M | +2.2% |
| Q2 2025 | $720.3M | +4.1% |
| Q1 2025 | $664.8M | +2.3% |
| Q4 2024 | $729.4M | +4.8% |
RVTY's revenue has grown year over year for nine quarters in a row: $729M last quarter, up 4.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 13% | +1.3 points |
| Q2 2026 | 12% | -0.4 points |
| Q1 2026 | 11% | -0.2 points |
| Q4 2025 | 14% | -1.8 points |
| Q3 2025 | 12% | -2.6 points |
| Q2 2025 | 13% | +0.2 points |
| Q1 2025 | 11% | +4.1 points |
| Q4 2024 | 16% | +5.2 points |
RVTY's operating margin was 13% last quarter, up 1.3 points from the same quarter a year ago.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over RVTY on cash flow, with more consistent year-over-year improvement.
RVTY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $152.4M | +27% |
| Q2 2026 | $180.9M | +57% |
| Q1 2026 | $95.5M | -15% |
| Q4 2025 | $161.8M | +8% |
| Q3 2025 | $120M | -4.4% |
| Q2 2025 | $115.5M | -15% |
| Q1 2025 | $112.2M | -14% |
| Q4 2024 | $149.8M | -13% |
RVTY still generates free cash flow, though less than at its 2021 peak: $590M over the past year.
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has 893M diluted shares, down 0.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
RVTY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +197K shares |
| 1 year | -3.1% | -3.6M shares |
| 3 years | -10% | -12.4M shares |
| 5 years | -2.8% | -3.2M shares |
| Available history | +0.3% | +325K shares |
RVTY has the edge over LLY on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $95,000 |
| Q2 2026 | $16M |
| Q1 2026 | $86.5M |
| Q4 2025 | $168.3M |
| Q3 2025 | $205M |
| Q2 2025 | $293.9M |
| Q1 2025 | $153.6M |
| Q4 2024 | $185.2M |
RVTY spent $271M buying back its own shares over the past year, down 68% from the year before.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY has the edge over RVTY on leverage, with a lower net debt burden relative to earnings.
RVTY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.6x | Moderate |
| Q2 2026 | 2.8x | Moderate |
| Q1 2026 | 3.0x | Elevated |
| Q4 2025 | 3.0x | Elevated |
| Q3 2025 | 3.0x | Moderate |
| Q2 2025 | 2.8x | Moderate |
| Q1 2025 | 2.6x | Moderate |
| Q4 2024 | 2.6x | Moderate |
RVTY's net debt is about 2.6 years of its operating earnings (EBITDA), down from 3.0 years a year ago.
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
RVTY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 74.3 | Overbought |
| Stochastic | 76.5 | Neutral |
RVTY's weekly RSI is 74 (overbought) and its Stochastic is 77 (neutral).
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY has the edge over RVTY on valuation relative to its sector.
RVTY PE vs Healthcare Sector
| Metric | RVTY | Sector median | Relative |
|---|---|---|---|
| PE | 70x | 26x | 170% above |
| PE % | 91 | 29 | 62 pts above |
RVTY is trading at 70x earnings, a 170% premium to the Healthcare sector's median of 26x.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY is in an uptrend: it's above all five of its weekly moving averages, and 79% above its 200-week average.
RVTY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $154.7 | 1.5% above |
| 20 week MA | $134.0 | 17% above |
| 50 week MA | $112.2 | 40% above |
| 100 week MA | $105.9 | 48% above |
| 200 week MA | $110.0 | 43% above |
RVTY has climbed back above all five of its weekly moving averages, and it's now 43% above its 200-week average.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has finished every year since 2020 higher, and it's up 32% so far in 2026.
RVTY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $97.1 | $139.7 | +44% |
| 2021 | $139.7 | $193.8 | +39% |
| 2022 | $193.8 | $140.6 | -27% |
| 2023 | $140.6 | $109.3 | -22% |
| 2024 | $109.3 | $112.0 | +2.5% |
| 2025 | $112.0 | $96.8 | -14% |
| 2026 YTD | $96.8 | $157.0 | +62% |
RVTY has the edge over LLY on returns for 2026, with the stronger performance.